Search Results - mo+reza+ebrahimkhani

4 Results Sort By:
CRISPR Platform & Portfolio
While genomic research has identified many genetic targets that have the potential to modify the course of a disease, there has been little translation of that into genetic therapies. However, the discovery of clustered regularly interspaced short palindromic repeat (CRISPR) segments and the subsequent development of CRISPR systems in 2011 revolutionized...
Published: 6/8/2023   |   Inventor(s): Radwa Ewaisha, Shayesteh Roshdi Ferdosi, Karen Anderson, Sri Krishna, Farzaneh Moghadam, Samira Kiani, Mo Reza Ebrahimkhani
Keywords(s):  
Category(s): Bioanalytical Assays, Chemistries & Devices, Cancer Therapeutics, Genomic Assays/Reagents/Tools, Life Science (All LS Techs), Non-Cancer Therapeutics, Pharmaceuticals
CRISPR Platform & Portfolio
While genomic research has identified many genetic targets that have the potential to modify the course of a disease, there has been little translation of that into genetic therapies. However, the discovery of clustered regularly interspaced short palindromic repeat (CRISPR) segments and the subsequent development of CRISPR systems in 2011 revolutionized...
Published: 6/8/2023   |   Inventor(s): Samira Kiani, Mo Reza Ebrahimkhani, Swechchha Pradhan, Farzaneh Moghadam
Keywords(s):  
Category(s): Life Science (All LS Techs), Pharmaceuticals, Non-Cancer Therapeutics, Genomic Assays/Reagents/Tools, Bioanalytical Assays, Chemistries & Devices, Cancer Therapeutics
CRISPR Platform & Portfolio
While genomic research has identified many genetic targets that have the potential to modify the course of a disease, there has been little translation of that into genetic therapies. However, the discovery of clustered regularly interspaced short palindromic repeat (CRISPR) segments and the subsequent development of CRISPR systems in 2011 revolutionized...
Published: 2/23/2023   |   Inventor(s): Samira Kiani, Xiao Wang, David Menn, Mo Reza Ebrahimkhani
Keywords(s):  
Category(s): Bioanalytical Assays, Chemistries & Devices, Life Science (All LS Techs), Non-Cancer Therapeutics, Pharmaceuticals, Cancer Therapeutics, Genomic Assays/Reagents/Tools
CRISPR Platform & Portfolio
While genomic research has identified many genetic targets that have the potential to modify the course of a disease, there has been little translation of that into genetic therapies. However, the discovery of clustered regularly interspaced short palindromic repeat (CRISPR) segments and the subsequent development of CRISPR systems in 2011 revolutionized...
Published: 2/23/2023   |   Inventor(s): Samira Kiani, Mo Reza Ebrahimkhani, Jennifer Chapman
Keywords(s):  
Category(s): Cancer Therapeutics, Bioanalytical Assays, Chemistries & Devices, Genomic Assays/Reagents/Tools, Life Science (All LS Techs), Pharmaceuticals, Non-Cancer Therapeutics